nicotine has been researched along with Amyloid Deposits in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gräslund, A; Ilag, L; Jarvet, J; Luo, J; Österlund, N; Roos, PM; Sholts, SB; Wallin, C; Wärmländer, SKTS | 1 |
| Arrazola, MS; Carvajal, FJ; Farias, GG; Godoy, JA; Inestrosa, NC; Rios, JA; Serrano, FG; Vargas, JY | 1 |
| Zhao, B | 1 |
| Chen, Q; He, W; Huang, YY; Li, FL; Liu, NQ; Liu, Q; Lu, ZB; Qin, C; Zhang, J; Zhao, BL; Zhu, H | 1 |
| Bednar, I; Court, J; Hall, R; Hellström-Lindahl, E; Johnson, M; Lee, M; Mousavi, M; Nordberg, A; Perry, E | 1 |
1 review(s) available for nicotine and Amyloid Deposits
| Article | Year |
|---|---|
Natural antioxidants protect neurons in Alzheimer's disease and Parkinson's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Flavonoids; Neurons; Nicotine; Oxidative Stress; Parkinson Disease; Phenols; Plaque, Amyloid; Polyphenols; Tea | 2009 |
4 other study(ies) available for nicotine and Amyloid Deposits
| Article | Year |
|---|---|
Alzheimer's disease and cigarette smoke components: effects of nicotine, PAHs, and Cd(II), Cr(III), Pb(II), Pb(IV) ions on amyloid-β peptide aggregation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cadmium; Chromium; Cigarette Smoking; Humans; Ions; Lead; Nicotine; Peptide Fragments; Plaque, Amyloid; Polycyclic Aromatic Hydrocarbons; Risk Factors; Smoking | 2017 |
Nicotine prevents synaptic impairment induced by amyloid-β oligomers through α7-nicotinic acetylcholine receptor activation.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Androstadienes; Animals; beta Catenin; Bungarotoxins; Cells, Cultured; Dendrites; Disks Large Homolog 4 Protein; Hippocampus; Intracellular Signaling Peptides and Proteins; Maze Learning; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurites; Neurons; Nicotine; Patch-Clamp Techniques; Peptide Fragments; Phosphatidylinositol 3-Kinases; Plaque, Amyloid; Presenilin-1; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins; Signal Transduction; Synapsins; Wnt Proteins; Wnt Signaling Pathway; Wortmannin | 2013 |
Nicotine attenuates beta-amyloid-induced neurotoxicity by regulating metal homeostasis.
Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloidosis; Animals; Cell Survival; Copper; Hippocampus; Homeostasis; Humans; Metals; Mice; Mice, Transgenic; Molecular Chaperones; Neuroprotective Agents; Nicotine; Peptide Fragments; Plaque, Amyloid; Reactive Oxygen Species; Receptors, Nicotinic; Superoxide Dismutase; Superoxide Dismutase-1 | 2006 |
Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw).
Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Animals; Astrocytes; Brain Chemistry; Cell Count; Cerebral Cortex; Disease Models, Animal; Disease Progression; Drug Administration Schedule; Female; Glial Fibrillary Acidic Protein; Hippocampus; Humans; Immunohistochemistry; Male; Mice; Mice, Transgenic; Nicotine; Olfactory Pathways; Peptide Fragments; Plaque, Amyloid; Sex Factors; Treatment Outcome | 2002 |